Skip to content

Randomized Controlled Compare The Patient-Reported Outcome-Based Quality of Life Management Versus Usual Care After Gastrointestinal Tumors Patients Receiving Ambulatory Chemotherapy

Randomized Controlled Compare The Patient-Reported Outcome-Based Quality of Life Management Versus Usual Care After Gastrointestinal Tumors Patients Receiving Ambulatory Chemotherapy

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083290
Enrollment
Unknown
Registered
2024-04-19
Start date
2023-04-06
Completion date
Unknown
Last updated
2024-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal cancer

Interventions

Geoup A: When the severity of out-of-hospital toxic and side effects of patients exceeds the warning value, mitigation measures are given
Geoup B:Routine follow-up

Sponsors

Ordos Central Hospital, Inner Mongolia
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients =18 years old who are pathologically diagnosed with gastrointestinal malignancies and intend to receive daytime chemotherapy; ?KPS score =70 points; (3) Before chemotherapy, there were no abnormalities in liver and kidney function, blood routine and electrocardiogram. Blood tests must meet the requirements of white blood cells 3.5×10^9L, neutrophils > 1.5×10^9, platelets > 85×10^9/L, alkaline phosphatase < 2.5 times the upper limit of normal value, alanine aminotransferase < 2.5 times the upper limit of normal value, bilirubin < 1.5 times the upper limit of normal value. (Upper limit of normal 1.5 times; (4) CT and MRI have no contraindications for tumor site evaluation. (5) Patients who will receive daytime chemotherapy in our hospital for four consecutive cycles or more; (6) The patient has completed the wechat questionnaire or his close relatives can complete the wechat questionnaire; 7. Informed consent and signed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients who cannot use wechat independently and cannot use wechat with the assistance of family members; (2) Patients who could not understand the content of the questionnaire; (3) Patients who are unwilling to fill in the questionnaire; (4) Patients undergoing concurrent radiotherapy; (5) Patients with uncontrolled intracranial metastases and who have received brain radiotherapy; (6) Patients with malignant tumors in other sites; ? Patients with unstable mental state, such as hysteria; (8) Patients with incomplete or complete intestinal obstruction;

Design outcomes

Primary

MeasureTime frame
European Organization for Research and Treatment,EORTC;

Secondary

MeasureTime frame
Dietary assessment;

Countries

China

Contacts

Public ContactLi Quanfu

Ordos Central Hospital, Inner Mongolia Ordos Clinical Medical College, Inner Mongolia

2805459764@qq.com+86 477 836 3279

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026